WO2024003825 - AN IMPROVED ASSAY METHOD OF ANTIBODY
National phase entry is expected:
Publication Number
WO/2024/003825
Publication Date
04.01.2024
International Application No.
PCT/IB2023/056773
International Filing Date
29.06.2023
Title **
[English]
AN IMPROVED ASSAY METHOD OF ANTIBODY
[French]
PROCÉDÉ DE DOSAGE AMÉLIORÉ D'ANTICORPS
Applicants **
KASHIV BIOSCIENCES, LLC
20, New England Avenue
Piscataway, New Jersey 08854, US
Inventors
PATEL, Rajeshwari
A 302, Samprat Residancy, Opp. Nilkanth Villa, Shilaj, Ahmedabad, Gujarat
Ahmedabad 380058, IN
ANIDIL KIZHAKINAGATH, Praveen Kumar
D202, Shree Lakshmi Narayan Residency, South Bopal, Ahmedabad, Gujarat
Ahmedabad 380058, IN
Priority Data
202221037354
29.06.2022
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
USPTO
* |
| * | |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1234 | |
| EPO | Filing, Examination | 7338 | |
| Japan | Filing | 531 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 2205 |
Total: 11883 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present invention relates to a method of analysis for estimation of relative potency of antibody of interest using beta-hexosaminidase degranulation in human cell line. The present invention relates to characterization of functional assay of anti-lgE antibody with beta-hexosaminidase. Every area of the biomedical science is in need of a system to assay chemical and biochemical reactions and determine the presence and quantity of a particular analyte. Numerous methodologies have been developed over the years to meet the demands of these fields. In general, limitations exist in the areas of specificity and sensitivity of most assay system.[French]
La présente invention concerne un procédé d'analyse pour l'estimation de la puissance relative d'un anticorps d'intérêt à l'aide d'une dégranulation de β-hexosaminidase dans une lignée cellulaire humaine. La présente invention concerne la caractérisation d'un dosage fonctionnel d'anticorps anti-IgE avec de la β-hexosaminidase. Chaque branche de la science biomédicale a besoin d'un système pour analyser des réactions chimiques et biochimiques et déterminer la présence et la quantité d'un analyte particulier. De nombreuses méthodologies ont été développées au fil du temps pour satisfaire les demandes dans ces domaines. En général, des limitations existent dans les branches de spécificité et de sensibilité de la plupart des systèmes de dosage.